| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |